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ABSTRACT: The marine environment is characterized by a wide diversity of microorganisms among which 
marine bacteria. To insure their survival in hostile conditions where they face high competition with pathogenic 
microorganisms, they produce various kinds of bioactive molecules within biofilms with unique structural and 
functional features. As example: marine peptides which provide a broad spectrum of antimicrobial, antitumoral, 
antiviral and anti-inflammatory activities, in addition to marine exopolysaccharides showing antifouling and 
antifungal activities, immunomodulatory properties, emulsion stabilization capacity with other various 
potentials. Some biofilms have shown a beneficial role for aquaculture, among which enhancement of growth 
performance and improvement of water quality, while others are threatening not only aquaculture and maritime 
fields, but also medicine and food industry. Thus, marine bioactive compounds are promising preventing agents 
for the establishment and growth of fouling microorganisms, which may be useful in different fields in order to 
decrease economic losses and avoid foodborne illnesses. 
Keywords: Marine biomolecules; Biofilms; Health issues; Aquaculture. 
1. INTRODUCTION 
The marine environment hosts an immense biological, chemical and ecological diversity [1]. It is 
characterized by hostile environmental conditions in terms of variation of salinity, temperature and pressure [2] 
which have favored production of a great variety of novel bioactive molecules with unique structural and functional 
features. These polymeric substances are of renewed interest to many sectors of industrial human activities 
including food industries, pharmaceuticals and drug delivery due to their diverse biological and chemical properties 
such as antitumor, immunostimulatory, anti-inflammatory, antibacterial, antifouling and antioxidant activities [3].  
Many naturally bioactive compounds are secreted on biological or non-biological surfaces submerged in the 
marine environment as living tissues, aquatic equipments and water distribution systems which may be covered with 
densely colonized sessile communities known as biofilms, enclosing microbial cells [2, 4]. The main advantage of 
biofilm formation is the protection of microorganisms from attack by bacterial and viral pathogens which extend their 
survival periods in extreme marine environments [5]. Additionally, it has been used as an ecofriendly strategy 
whereby substrate based aquaculture using biofilms has contributed to improvement of water quality resulting in 
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enhanced growth of marine organisms of interest (fishes, shellfishes, and aquatic plants). Nevertheless, these sessile 
biological assemblies may turn virulent and cause health diseases since they may develop on seafood. They also lead 
to significant economic losses in the maritime field due to biofouling and materials biocorrosion [6]. 
In this review, we give a general overview on the main classes of bioactive molecules produced by marine 
bacteria and their diverse biological activities which provide promising applications in various fields. We also 
describe their living modes which may have advantages and inconveniences for many aquatic organisms and 
eventually to human health as well as to the whole marine ecosystem. 
2. MARINE DIVERSITY 
Oceans are colonized by microbial species that are essential for marine ecosystems and have pivotal roles in 
global biogeochemical cycles. The marine environment is characterized by a taxonomic richness where bacteria are 
very abundant. A recent metagenomics study has reported the partition of bacterial genera communities to geographic 
locations. Cyanobacteria, Alphaproteobacteria and Flavobacteria dominate the photic zone samples while the aphotic 
zone is colonized mainly by Alphaproteobacteria, Deferribacteres, Deltaproteobacteria and Gammaproteobacteria [7]. 
A significant part of the world ocean is characterized by harsh conditions in terms of low nutrients, low 
concentrations of biodegradable organic carbon, variation of temperature, pressure and salinity. Thus, 
microorganisms are classified into halotolerant: which do not require salt for growth but tolerate it, then can grow in 
moderately salty environments, and halophilic: for which the presence of salt is essential for their survival and 
growth, then they only thrive in highly saline environments [8].  
In parallel, microorganisms are adapted to osmotic stress. They have an endogenous balance of pressure and 
resistance to osmotic stress apart from any external osmoprotection. Therefore, they carry the genetic information 
and the enzymatic machinery necessary for osmotolerance which allow them to maintain an internal osmotic 
pressure higher than the surrounding environment [9]. 
Hence, bacterial adaptations represent a driving force leading to new secondary metabolic products that function 
as a defense strategy against natural predators in order to insure their survival [5]. In this regard, the most reported genera 
from which novel metabolites have been isolated are phylogenetically diverse, including among them Pseudomonas, 
Alteromonas, Vibrio, Bacillus, Streptomyces. For example the widespread genus Pseudomonas, is a group of gram 
negative and easily cultivable gamma-proteobacteria that includes numerous marine species of great importance due to 
their production of various useful compounds such as antibiotics, enzymes, antitoxins, antitumorals and antivirals [2]. 
Moreover, widespread marine actinomycetes are known by their production of a great variety of bioactive 
compounds as was reported with Pseudonocardia sp. HS7, Nocardiopsis sp. strain HYJ128, Marinispora strain 
CNQ-140, Streptomyces sp. CNQ343 and many other species [10] as shown in Table 1. 
On the other hand, Vibrio is an example of bacterial genus which belongs to microbial pathogens of 
clinical importance for humans and many marine animals. It contains different species many of which of marine 
and other aquatic environments, but V. alginolyticus, V. vulnificus, V. parahaemolyticus, V. cholerae, V. fluvialis 
and V. mimicus are the most dangerous reported species to humans and other animals. They have been associated 
with infections in case of wounds or after exposure to polluted water, or after eating contaminated food [11]. Thus 
many researchers have discovered natural compounds isolated from sponge bacterial symbionts inhibiting virulent 
Vibrio species such as docosane acting against V. harveyi, V. parahaemolyticus and V. vulnificus [5].  
In addition, marine fungi are sources of structurally unique products. Many of marine fungal metabolites 
have been classified as potential therapeutic agents owned to their antimicrobial, anticancer, antiviral and 
antimarine fungal-inflammatory activities [10, 12] as shown in Table 1. 
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Table 1. Potential therapeutic bioactive molecules produced by marine bacteria and fungi. 
Marine 
microorganisms 








Pyolipic acid and 
phenazine-1-carboxylic acid 
Antifouling [10] 
Vibrio sp. WMBA Aqabamycins A−D Antibacterial [10] 
Bacillus subtilis  
strain 109GGC020 




Macrolactin V Antibacterial [10] 
Bacillus sp. 09ID194 Macrolactins X−Z Antibacterial [10] 
Bacillus licheniformis  
ATCC 14580 
BL00275 Antibiofilm [10] 




Streptomyces caelestis Citreamicin θ A-B-C Antibacterial [10] 
Streptomyces roseogilvus Griseoviridin Antibacterial [10] 
Streptomyces fradiae  
strain PTZ0025 
Fradimycins A-B Antibacterial [10] 
Kocuria palustris Kocurin Antibacterial [10] 
Pseudonocardia sp. Diazaanthraquinone Antibacterial [10] 
Streptosporangium 
strain DSZM 4594 
Iodinin Antibacterial [10] 
Streptomyces sp.  
SCSIO 10355 
Strepsesquitriol Anti-inflammatory [12] 
Streptomyces strain M491 T-Muurolol sesquiterpenes Cytotoxic [12] 
Micromonospora sp.  
strain WMMC-218 
Micromonohalimane B Antibacterial [12] 
Verrucosispora 
gifhornensis YM28-088 
Gifhornenolones Cytotoxic [12] 
Actinomycetes  
isolate CNH-099 
Neomarinones Cytotoxic [12] 
Erythrobacter sp.  
strain SNB-035 
Erythrazole Cytotoxic [12] 
Fungi 
Penicillium sp.  
SCS-KFD09 







Strain 95-1005C  
Chondrostereum sp. 
SF002 
Hirsutanol A Antitumoral [12] 
Aspergillus sp. CNL-523 Cryptosphaerolide Cytotoxic [12] 
Curvularia sp. strain M12 
Curvularin and  
(S)-dehydrocurvularin 
Antifungal [10] 
Penicillium thomii  
KMM 4667 
Thomimarine E Anti-inflammatory [12] 
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Marine 
microorganisms 
Source Biomolecules Activity References 
Cladosporium spp. 
Xestodecalactones A–C 




Streptomyces sp.  
strain 12A35 
Lobophorins H and I Antibacterial [10] 
Penicillium sp. β-resorcylicacid lactones Antifungal [10] 
Aspergillus sp. Didehydrosydonic acid Cytotoxic [12] 
Aspergillus sp. Disydonols Cytotoxic [12] 




Aspergillus versicolor Insulicolide A Cytotoxic [12] 





Table 2. Potential therapeutic bioactive molecules produced by seaweeds and sponges. 
Marine 
organisms 
Source Biomolecules Activity References 
Seaweeds 
Callophycus serratus 
5- and 16-membered 
bromophycolides J-Q 
Antibacterial [16] 
Neurymenia fraxinifolia Neurymenolides A and B Antibacterial [16] 
Ecklonia kurome 




Ecklonia cava Dieckol Fungicidal [16] 
Ecklonia cava Eckol Antimicrobial [16] 
Ishige foliacea Octaphlorethol A Anti-inflammatory [16] 
Eisenia arborea Phlorofucofuroeckol B Anti-inflammatory [16] 
Vidalia obtusaloba Vidalols A and B Anti-inflammatory [16] 




Eisenia bicyclis Fucosterol Antidepressant [16] 
Sargassum fusiforme Saringosterol3,6,17-trihydroxy Antidepressant [17] 
Turbinaria conoides Stigmasta-4,7,24(28)-triene Antifungal [17] 











Phycopsis sp. Dichloromethane Antibacterial [18] 
Agelas dispar Methanol bromopyrrole alkaloids Antibacterial [18] 
Latrunculia sp.  
and Negombata sp. 
Discorhabdin R Antibacterial [18] 
Petrosia sp. Methanol soluble extract Cytotoxicity [18] 
Cymbastela sp. Aglestatin A Cytotoxicity [18] 
Pachastrella sp.  
and Jaspis sp. 
Pectenotoxin II and Psammaplin 
A 
Antitumoral [18] 
Cymbastela sp. Methylicosadienoicacids Larvicidal [18] 
Hyrtios sp. Puupehenone Antiviral/Antifungal [18] 
Fasciospongia covernosa Cacospongionolide B Antimicrobial [18] 
Polyfibrospongia sp. Hennoxazoles A-D Antiviral [19] 
Polyfibrospongia sp. Miyakolide Antitumoral [19] 
Axinella sp./ 
Halichondrida 
Axinellamines B–D Antibacterial [19] 
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Marine 
organisms 
Source Biomolecules Activity References 
Cribrochalina sp. Cribrostatin 6 Antibacterial [19] 
Aaaptos aaptos Isoaaptamine Antibacterial [19] 
Arenosclera brasiliensis Arenosclerins A–C Antibacterial [19] 
Arenosclera brasiliensis Haliclona cyclamine E Antibacterial [19] 
Caminus sphaeroconia Caminosides A–D Antibacterial [19] 
Jaspis sp. Jaspamide Antiviral [19] 
Hymeniacidon sp. Monamphilectine A Antimalarial [19] 
 
Moreover, the marine environment contains diverse marine multicellular macroscopic organisms 
including seaweeds and invertebrates which represent other potential resources of natural products. 
Seaweeds (also called macroalgae) are an heterogeneous group of macroscopic, multicellular, marine 
macroalgal species; they can be divided into three main phyla: red (Rhodophyceae), brown (Phaeophyceae), 
and green (Chlorophyceae) macroalgae. They comprise a highly significant element of the marine ecosystem 
contributing a major feeding ground for marine lives as well as potentially therapeutic resources for human. 
Numerous secondary bioactive metabolites including carotenoids, polyphenolics, polysaccharides, and sterols 
have been isolated from seaweed and applied in different industrial usages due to their health promoting 
therapeutic qualities combatting various human ailments, comprising antihypertensive, antioxidant, 
antithrombotic and immunomodulatory properties [13].  
On the other hand, invertebrates comprise a wide range of animal species belonging to various phyla 
with different morphological structures and physiology, including Mollusca, Arthropoda, Porifera and 
Echinodermata, from which secondary metabolites mainly alkaloids, terpenoids and steroids, have shown 
biological activities and are commercially applied [14]. 
Additionally, marine invertebrates have been reported to actively interact with their associated 
bacterial symbionts resulting in the discovery of new compounds as biosurfactants and exopolysaccharides, 
with application in pharmaceutical and medical fields for their antifungal, antiprotozoal, antiviral and 
antifouling functions [15]. The exploration of the different phyla is related to the discovery of a greater 
amount of natural substances with functional biodiversity as shown in Table 2. 
3. MARINE BIOMOLECULES WITH RELEVANT CHEMICAL AND THERAPEUTIC 
PROPERTIES 
3.1. Chitin and chitosan 
Chitin and chitosan are natural glucosamine biopolymers mostly found in the structural backbone 
exoskeleton of marine invertebrates. Chitin is a neutral crystalline substance with a structure of n-acetyl-
glucosamine monomerswidely derived from shrimps, crabs and squid which revealed an important role in 
maintaining cutaneous homeostasis and neutralizing free radicals activity [20]. Its deacetylated derivative 
called chitosan is found in lobster, crab, shrimp and also in mollusks exoskeletons. It is recognized by its 
multiple applications in cosmeceutical formulations for skin care, as moisturizer because of its water 
absorbing properties. Its oligomers revealed an important role in stimulating fibroblast production, providing 
wound healing benefits, and exhibiting antioxidant and metalloproteinase inhibiting effects. It has also 
antimicrobial activity against bacteria, yeasts and fungi. In the form of nanoparticles, chitosan helps to protect 
from aggressive environmental factors such as light and oxidation [20]. 
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Additionally, marine bacterial chitinases are exoenzymes that play an important role in the nutrient 
cycling and waste management in the oceans. They convert chitin to biologically useful carbon and nitrogen 
forms for marine organisms and biodegrade exoskeletal chitinous wastes generated from the production and 
processing of shellfish to reduce environmental pitfalls [21].  
3.2. Carotenoids 
Carotenoids, or tetraterpenoids, are important yellow, red, and orange coloured pigments isolated from 
photosynthetic bacteria, algae and plants that have relevant antioxidant roles. Physiologically, oxidative stress is 
implicated in pathological degenerative processes and aging, atherosclerosis, cancer, malaria, neurodegenerative 
diseases and arthritis. Thus, carotenoids have proven their ability to prevent, delay, or neutralize the effects of 
oxidative stress and suppression and/or scavenging of free radicals. Beta carotene and lycopene have been 
reported to remediate ultraviolet oxidative damage to the skin and retina [22]. In addition, lutein and zeaxanthin 
have shown a protecting role against age-related macular degeneration through antioxidant and light protective 
mechanisms [23]. Zeaxanthin, has also shown to have various beneficial effects for human health due to its 
ability to quench free radicals, exert antioxidant effects, as well as decrease inflammation [24]. Astaxanthin, 
another carotenoid has gained a growing interest as a multi-target pharmacological agent against neurological 
diseases such as Alzheimer’s disease, Parkinson’s disease, neuropathic pain, aging, depression, and autism.  
It has shown a neuroprotective effects due to its anti-inflammatory, antioxidative, and anti-apoptotic properties to 
tackle neurodegeneration [25, 26]. Moreover, several biological properties are provided by fucoxanthin, a marine 
natural compound produced by brown algae and diatoms, reported to provide anti-obesity, anti-diabetic, 
anticancer, antioxidant and antimicrobial activities [27].  
3.3. Polysaccharides 
Polysaccharides are the high molecular weight carbohydrate molecules, mostly polymers of glucose, 
linked through glycosidic bonds. They have known a grown interest in various industries which demand 
applications of natural polymers for their diverse biological activities. For example, a sulfated O-
polysaccharide isolated from the marine bacterium Poseidonocella sedimentorum KMM 9023T has shown 
high anticancer activity. It inhibits colony formation of human colorectal adenocarcinoma HT-29, human 
breast adenocarcinoma MCF-7 and human malignant melanoma SK-MEL-5 cells [28]. Anticancer therapeutic 
properties have also been shown for other carbohydrate types, as is the case of the sulfated lipopolysaccharide 
isolated from the marine bacterium Cobetia litoralis KMM 3880 3880T. It inhibits colony formation of 
human melanoma SK-MEL-28 and colorectal carcinoma HTC-116 cells [29].  
Additionally, these natural polymers are used in cosmetics in order to prevent aging, inflammation, and 
skin degradation as they are formulated with ingredients including vitamins, minerals and antioxidants [30]. 
They are also commercialized as emulsifiers, gelling agents, viscosifiers, stabilizers, and texture enhancers 
provided by fucoidans isolated from brown algae, carrageenans from red algae, and alginate and agar from 
brown and red algae [31].  
3.4. Peptides 
Recently, many biologically active compounds of peptidic nature have proven their ability to impair 
biofilms development. They may represent a biofilm preventing strategy for investigation in aquaculture, 
maritime fields and food industries in order to reduce economical losses worldwide [32].  
For example, a peptide molecule produced by Pseudoalteromonas sp. strain 3J6 called alterocin 
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impaired the ability of initial attachment of Paracoccus sp. strain 4M6, Vibrio sp. D01 and Vibrio tapetis to 
form biofilms. It has also impaired biofilm development by three human pathogenic strains: Pseudomonas 
aeruginosa, Salmonella enterica and Escherichia coli [33]. 
In the same way, another Pseudoalteromonas strain, Pseudoalteromonas sp. strain 41, has impaired 
biofilm development ofmany marine bacterial strains including Pseudoalteromonas sp. strain 3J6, Paracoccus 
sp. strain 4M6, Alteromonas sp. 1J3, Algibacter sp. 1M6, Micrococcus sp. 5J6 and Colwellia sp. 4J3 [34]. 
In addition, many microbes associated with marine living surfaces have been reported to secrete 
peptides with antifouling activity which inhibits the adhesion of biofilm bacteria and microalgae and showed 
inhibitory activities against larval forms of barnacle, polychaete, ascidian and spores of macroalgae [35]. 
3.5. Antibiotics  
Marine microorganisms represent a significant source for the development of antibiotics. Most of them 
are synthesized by bacteria, in particular, actinomycetes which produce diverse products with clinical or 
pharmaceutical applications due to their broad spectrum of biological properties. For example, marthiapeptide A 
isolated from M. Thermotolerans SCSIO 00652, desotamide B isolated from Streptomyces scopuliridi  
SCSIO ZJ46, marfomycins A, B, and E isolated from Streptomyces drozdowiczii SCSIO 10141 and 
vitroprocines A-J derived from Vibrio sp. QWI-06 providing all of them antimicrobial activities. In addition, 
there are antibiotics with potent antitumor properties, they have been designated as spirotetronate polyketides, 
like lobophorin F isolated from Streptomyces SCSIO 01127, lobophorin H isolated from Streptomyces sp. 
12A35S and abyssomicin C isolated from Verrucosispora strain AB 18-032 [36, 37]. 
On the other hand, marine fungi have been also considered as an excellent source of bioactive 
compounds since the discovery of the antibiotic cephalosporin. As example of natural compounds isolated 
from fungi, there are gliotoxin isolated from an Aspergillus sp., prenylxanthones and emerixanthones A–D 
isolated from Emericella sp. SCSIO 05240 and engyodontiumone H purified from Engyodontium album 
DFFSCS021 providing antifungal and antibacterial properties with many other antibiotics providing various 
biological activities [36]. 
4. IMPACTS OF MARINE BIOFILMS 
4.1. Advantages 
Bacterial biofilms are an extracellular matrix mainly composed of polysaccharides, proteins and lipids. It 
facilitates signals exchange and nutrient uptake between different bacterial species, and with other symbiotic 
microorganisms, like fungi and microalgae. This sessile form gives the bacterial community protection against  
a huge number of environmental stressors such as antimicrobial agents, predators, UV radiation, etc. [5, 38]. 
The nutritional composition of biofilms is considerably appropriate to fish dietary needs. Consequently, 
food availability as well as water quality improved by bacterial biofilms enhance aquaculture growth and 
production. 
It has been reported in a research that application of biofilm during the culture of fingerlings of the fish 
Catla catla has shown lower concentrations of total ammonia in comparison with control treatment [5]. Then, 
the presence in biofilms of nitrifying bacterial communities belonging to Nitrosomonas and Nitrosococcus 
genera helps in the management of water quality by decreasing ammonium level in cultured water with a parallel 
increase of nitrite and nitrate concentrations [6]. 
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Aquaculture used to need water exchange for feed addition as well as preventing accumulation of toxic 
substances. However, frequent water exchange is expensive and may increase the risk of introducing bacterial 
pathogens and toxic metabolites, but since the use of biofilm has been introduced in aquaculture ponds, it is not 
required to exchange water [5, 6]. The use of biofilms sequesters excess nutrients such as dissolved phosphorus, 
ammonia ions and nitrates that are accumulated in aquaculture ponds including bacteria of the genera 
Nitrobacter, Nitrococcus, Nitrospira, and Nitrospin. It does not only maintain water quality but also reduce the 
occurrence of pathogenic microorganisms which may suppress microbial infection and prevent diseases. For 
example, Vibrio strain C33 a marine bacterium associated with the aquaculture of bivalve Agropecten purpuratus 
has been reported to produce bioactive compounds controlling the growth of pathogenic strains forming biofilms 
such as Vibrio alginolyticus, Vibrio anguillarum, Vibrio parahaemolyticus and Vibrio splendidus [39].  
On the other hand, there are several situations in which higher organisms encourage biofilm formation by 
protective biofilms. One example of this feature is the macroalga Ulva lactuca, it encourages colonization by the 
marine gram negative bacterium, Pseudoalteromonas tunicate. This endophytic bacterium produces antifouling 
compounds identified as a large extracellular protein that inhibits colonization by other undesirable bacteria [40]. 
Thus, biofilm can be used as a novel alternative strategy of disease control in marine fisheries and 
aquaculture industries in order to improve growth performance and health conditions of aquatic organisms [41, 
42]. It can also serve as active biofilters to absorb and degrade excessive nutrients and remove ammonia in 
seawater supply systems [43].  
4.2. Inconvenients 
Over the past few decades, the consumption of raw food including seafood products has grown as it 
has a high nutritional value. It contains proteins, omega-3 fatty acids, minerals and vitamins. Consequently, 
the occurrence of foodborne illnesses is increasing because of these new nutritional trends making food safety 
a universal issue [44]. 
Consumers are most vulnerable to foodborne illnesses because of dangerous bacterial pathogens               
found as biofilms on seafood formed by Listeria spp., Salmonella spp., Vibrio spp. (V. cholerae,                                
V. parahaemolyticus, V. vulnificus), Clostridium spp. (C. perfringens, C. botulinum), Campylobacter spp., 
Shigella spp., etc. Other species of the genera Mycobacterium are also deleterious to humans health especially 
Mycobacterium marinum as well as a number of Streptococcus, Aeromonas, Erysipelothrix, and Pseudomonas 
species [45].  
Some bacteria may produce potent natural toxins. Many of them are thermostable, and since they 
cannot be destroyed by food preparation methods (cooking, frying, freezing, etc.) they lead to acute illnesses 
such as emetic reaction, gastroenteric symptoms, and neurologic reactions [46].  
When microorganisms form biofilm on food, they survive for long periods. Consequently, antibiotics 
and numerous chemical compounds habitually used in aquaculture to control the occurrence of these bacterial 
pathogens are less effective [47]. Moreover, these compounds have a negative impact not only on quality and 
safety of cultivated organisms (including oysters, mussels, fish and crustaceans) but also on human health, as 
well as on the environment [46]. Firstly, the excessive exposure may damage the nervous and immune 
systems and lead to cancer and impairment of reproductive development and function. Additionally, some 
seafood pathogens may become resistant to many drugs and the resistant determinants may be transmitted by 
horizontal gene transfer to bacterial human pathogens after consumption of contaminated seafood leading to 
dangerous outbreaks [47].  
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On the other hand, the marine environment is being progressively polluted by these wide varieties of 
drugs and chemicals. It is also affected by novel microbial communities colonization which may be developed 
on any submerged surface and cause biofouling and biocorrosion [48]. These ecological phenomena have 
major impacts on marine engineering contributing to economic losses worldwide. They can lead to reduction 
of heat transfer capacity of heat exchangers by 20 to 30% and decrease of underwater cameras and 
nephelometers effectiveness. They can also develop on ship hulls and boats which may increase their weight 
and consequently consumption of fuel, then increase CO2 emissions [49]. 
Thus, the discovery of novel secondary metabolites from the marine environment has been necessary 
to overcome biofilm issues occurring in marine habitats. An example of a non-toxic glycolipid biosurfactant 
named BS-SLSZ2 derived from a marine bacterium Staphylococcus lentus is used to treat aquaculture 
associated infections as it inhibits Vibrio harveyi and Pseudomonas aeruginosa biofilms. Vibrio harveyi 
biofilm is also inhibited by a lipopeptide of the fengycin family produced by the actinobacterium 
Nesterenkonia sp. MSA31, while another lipopeptide produced by a newly identified bacterium, Pontibacter 
korlensis strain SBK-47 named pontifactin exhibits an anti-adhesion potential against Vibrio cholerae. 
Therefore, marine secondary metabolites are taking a high interest for use as an eco-friendly manner in 
aquaculture ponds as they may act as biofilm controlling agents in order to decrease the usage of antibiotics in 
aquaculture settings [42, 50]. 
5. CONCLUSION 
Marine species are taxonomically diverse, which makes them of a renewed interest for the discovery of 
a wide range of novel natural molecules. Marine secondary metabolites are recognized by unique structural 
and functional features. They provide diverse biological activities such as antitumor, immunostimulatory, anti-
inflammatory, antibacterial, antifouling and antioxidant activities. Consequently, it makes them possess a 
great potential for exploitation in different areas such as pharmaceutical, cosmetics and food industries as well 
as maritime and aquaculture fields. Thus, the marine environment needs to be more explored to strengthen the 
use of natural bioactive compounds as an adequate alternative to synthetic molecules. 
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